AMGN analyst scorecard · Amgen
78 rating actions on AMGN in the last 12 months. Of 67 price targets that resolved, 31 were reached while they stood, 35 were replaced by the same firm first, and 1 fell short at their deadline. Ratings: 32% Buy-type, 64% Hold-type, 4% Sell-type. Consensus target $397, 14% below the last close.
Checked through 2026-10-29 · last close $460.01 (2026-10-29). Rebuilt every morning.
Targets reached while they stood
46.3% 31 of 67
Replaced before the deadline
52.2%
Short at the deadline
1.5%
Ratings vs XLV
4 of 5
Buy / Hold / Sell, 12 mo
32 / 64 / 4%
Consensus target
$397 -13.6%
What the Holds say: 50 Hold-type ratings on AMGN in the last 12 months carried a median target -4% from the price on the day; 72% sat below it.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| UBS | Buy | 2026-10-09 | $470 | 2 | 6 | 8 | — |
| Piper Sandler | Overweight | 2026-08-20 | $457 | 3 | 6 | 9 | 1 of 1 |
| Wells Fargo | Equal-Weight | 2026-10-12 | $430 | 1 | 1 | 2 | — |
| Oppenheimer | Outperform | 2026-10-23 | $480 | 0 | 1 | 1 | — |
| RBC Capital | Outperform | 2026-10-08 | $430 | 3 | 1 | 4 | 1 of 1 |
| Scotiabank | Sector Outperform | 2026-09-29 | $500 | 0 | 1 | 1 | — |
| Goldman Sachs | Buy | 2026-08-05 | $450 | 1 | 0 | 1 | — |
| TD Cowen | Buy | 2026-08-05 | $452 | 1 | 0 | 1 | — |
| Mizuho | Neutral | 2026-08-18 | $352 | 0 | 1 | 1 | — |
| Bernstein | Market Perform | 2026-08-06 | $345 | — | — | 0 | — |
| Leerink Partners | Outperform | 2026-02-04 | $355 | 0 | 1 | 1 | — |
| Morgan Stanley | Equal-Weight | 2026-10-07 | $359 | 1 | 7 | 8 | — |
| BMO Capital | Market Perform | 2026-10-12 | $415 | 1 | 3 | 4 | 1 of 1 |
| Argus Research | Buy | 2026-08-19 | $460 | 1 | 0 | 1 | — |
| Cantor Fitzgerald | Neutral | 2026-10-08 | $440 | 3 | 0 | 3 | — |
| Guggenheim | Neutral | 2026-10-13 | $378 | 2 | 0 | 2 | — |
| Truist Securities | Hold | 2026-10-07 | $380 | 1 | 2 | 3 | — |
| Barclays | Equal-Weight | 2026-10-21 | $400 | 2 | 1 | 3 | — |
| Citigroup | Neutral | 2026-08-07 | $405 | 3 | 1 | 4 | — |
| Canaccord Genuity | Hold | 2026-08-05 | $384 | 2 | 0 | 2 | — |
| Bank of America | Underperform | 2026-08-05 | $317 | 1 | 3 | 4 | 0 of 1 |
| Freedom Broker | Hold | 2026-02-12 | $375 | 1 | 0 | 1 | — |
| HSBC | Hold | 2026-09-10 | $425 | 1 | 0 | 1 | — |
| Baird | Underperform | 2026-08-05 | $230 | — | — | 0 | — |
| Jefferies | Hold | 2026-03-10 | $350 | 1 | 0 | 2 | 1 of 1 |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor AMGN carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-23 | Oppenheimer | Outperform | maintained | $439.26 | $480 | running to 2027-10-23 | +8.2% |
| 2026-10-21 | Barclays | Equal-Weight | maintained | $438.34 | $400 | running to 2027-10-21 | +11.5% |
| 2026-10-13 | Guggenheim | Neutral | maintained | $412.84 | $378 | running to 2027-10-13 | +9.4% |
| 2026-10-12 | BMO Capital | Market Perform | maintained | $417.57 | $415 | within 5% of price when set | +10.7% |
| 2026-10-12 | Wells Fargo | Equal-Weight | maintained | $417.57 | $430 | within 5% of price when set | +10.7% |
| 2026-10-09 | UBS | Buy | maintained | $414.87 | $470 | running to 2027-10-09 | +6.0% |
| 2026-10-08 | RBC Capital | Outperform | maintained | $407.44 | $430 | reached 2026-10-15 | +3.6% |
| 2026-10-08 | Cantor Fitzgerald | Neutral | maintained | $407.44 | $440 | reached 2026-10-22 | +3.6% |
| 2026-10-07 | Truist Securities | Hold | maintained | $413.08 | $380 | running to 2027-10-07 | -5.5% |
| 2026-10-07 | Morgan Stanley | Equal-Weight | maintained | $413.08 | $359 | running to 2028-04-07 | -5.5% |
| 2026-09-29 | Scotiabank | Sector Outperform | maintained | $423.64 | $500 | running to 2027-09-29 | -2.0% |
| 2026-09-10 | HSBC | Buy → Hold | downgrade | $382.47 | $425 | reached 2026-10-14 | -7.7% |
| 2026-09-08 | BMO Capital | Outperform → Market Perform | downgrade | $393.17 | $450 | replaced 2026-10-12, new $415 | -4.3% |
| 2026-09-08 | Cantor Fitzgerald | Neutral | reiterated | $393.17 | $400 | within 5% of price when set | -4.3% |
| 2026-09-04 | Wells Fargo | Equal-Weight | maintained | $437.23 | $435 | within 5% of price when set | +7.2% |
| 2026-08-20 | Piper Sandler | Overweight | maintained | $433.73 | $457 | reached 2026-10-29 | +18.4% |
| 2026-08-19 | Morgan Stanley | Equal-Weight | maintained | $442.36 | $362 | replaced 2026-10-07, new $359 | +21.5% |
| 2026-08-19 | Argus Research | Buy | maintained | $442.36 | $460 | within 5% of price when set | +21.5% |
| 2026-08-18 | Mizuho | Neutral | maintained | $425.28 | $352 | running to 2027-08-18 | +16.1% |
| 2026-08-18 | Cantor Fitzgerald | Neutral | maintained | $425.28 | $400 | reached 2026-09-08 | +16.1% |
| 2026-08-14 | Barclays | Equal-Weight | maintained | $415.21 | $380 | reached 2026-09-11 | +15.9% |
| 2026-08-10 | Guggenheim | Neutral | maintained | $417.20 | $388 | reached 2026-09-10 | +14.8% |
| 2026-08-07 | Citigroup | Neutral | maintained | $410.95 | $405 | within 5% of price when set | +11.7% |
| 2026-08-06 | Bernstein | Market Perform | maintained | $404.85 | $345 | running to 2027-08-06 | +10.0% |
| 2026-08-05 | Baird | Underperform | maintained | $407.83 | $230 | running to 2027-08-05 | +11.3% |
| 2026-08-05 | Canaccord Genuity | Hold | maintained | $407.83 | $384 | reached 2026-09-10 | +11.3% |
| 2026-08-05 | Bank of America | Underperform | maintained | $407.83 | $317 | running to 2027-08-05 | +11.3% |
| 2026-08-05 | Goldman Sachs | Buy | maintained | $407.83 | $450 | reached 2026-10-28 | +11.3% |
| 2026-08-05 | UBS | Buy | maintained | $407.83 | $440 | reached 2026-08-19 | +11.3% |
| 2026-08-05 | Morgan Stanley | Equal-Weight | maintained | $407.83 | $351 | replaced 2026-08-19, new $362 | +11.3% |
| 2026-08-05 | TD Cowen | Buy | maintained | $407.83 | $452 | reached 2026-10-29 | +11.3% |
| 2026-08-05 | Truist Securities | Hold | maintained | $407.83 | $362 | replaced 2026-10-07, new $380 | +11.3% |
| 2026-08-05 | Oppenheimer | Outperform | maintained | $407.83 | $450 | replaced 2026-10-23, new $480 | +11.3% |
| 2026-08-05 | Scotiabank | Sector Outperform | maintained | $407.83 | $450 | replaced 2026-09-29, new $500 | +11.3% |
| 2026-08-05 | RBC Capital | Outperform | maintained | $407.83 | $400 | within 5% of price when set | +11.3% |
| 2026-08-05 | Wells Fargo | Equal-Weight | maintained | $407.83 | $400 | within 5% of price when set | +11.3% |
| 2026-08-05 | BMO Capital | Outperform | maintained | $407.83 | $450 | replaced 2026-10-12, new $415 | +11.3% |
| 2026-07-29 | Barclays | Equal-Weight | maintained | $387.64 | $360 | replaced 2026-08-14, new $380 | +7.5% |
| 2026-07-13 | Bank of America | Underperform | maintained | $360.45 | $312 | replaced 2026-08-05, new $317 | +1.5% |
| 2026-07-13 | UBS | Buy | maintained | $360.45 | $420 | replaced 2026-08-05, new $440 | +1.5% |
| 2026-07-13 | Guggenheim | Neutral | maintained | $360.45 | $343 | within 5% of price when set | +1.5% |
| 2026-07-08 | Morgan Stanley | Equal-Weight | maintained | $367.99 | $333 | replaced 2026-08-05, new $351 | +6.4% |
| 2026-07-07 | Truist Securities | Hold | maintained | $368.10 | $340 | replaced 2026-08-05, new $362 | +5.3% |
| 2026-07-06 | Cantor Fitzgerald | Neutral | reiterated | $366.44 | $350 | within 5% of price when set | +4.8% |
| 2026-06-16 | Mizuho | Neutral | maintained | $347.84 | $303 | replaced 2026-08-18, new $352 | +6.6% |
| 2026-06-10 | Morgan Stanley | Equal-Weight | maintained | $337.73 | $340 | within 5% of price when set | +2.5% |
| 2026-05-20 | Argus Research | Buy | maintained | $331.57 | $375 | reached 2026-07-24 | -5.3% |
| 2026-05-14 | Piper Sandler | Overweight | maintained | $336.23 | $427 | reached 2026-08-19 | -4.2% |
| 2026-05-04 | Guggenheim | Neutral | maintained | $323.85 | $340 | within 5% of price when set | -6.9% |
| 2026-05-01 | Truist Securities | Hold | maintained | $329.82 | $327 | within 5% of price when set | -6.6% |
| 2026-04-21 | Canaccord Genuity | Hold | initiated | $344.86 | $366 | reached 2026-07-02 | -0.8% |
| 2026-04-13 | UBS | Buy | maintained | $349.82 | $400 | replaced 2026-07-13, new $420 | -4.5% |
| 2026-04-10 | Morgan Stanley | Equal-Weight | maintained | $351.02 | $326 | reached 2026-05-04 | -7.0% |
| 2026-04-09 | Guggenheim | Neutral | maintained | $355.60 | $351 | within 5% of price when set | -5.3% |
| 2026-04-08 | Cantor Fitzgerald | Neutral | reiterated | $349.81 | $350 | within 5% of price when set | -7.2% |
| 2026-03-10 | Jefferies | Hold | initiated | $375.43 | $350 | reached 2026-03-19 | -2.3% |
| 2026-02-20 | Barclays | Equal-Weight | initiated | $374.75 | $350 | reached 2026-03-19 | +9.1% |
| 2026-02-19 | Wells Fargo | Equal-Weight | maintained | $375.50 | $375 | within 5% of price when set | +13.4% |
| 2026-02-18 | Piper Sandler | Overweight | maintained | $379.73 | $432 | replaced 2026-05-14, new $427 | +14.9% |
| 2026-02-12 | Freedom Broker | Buy → Hold | downgrade | $366.20 | $375 | within 5% of price when set | +12.9% |
| 2026-02-06 | Argus Research | Buy | maintained | $384.32 | $400 | within 5% of price when set | +12.5% |
| 2026-02-06 | Guggenheim | Neutral | maintained | $384.32 | $347 | reached 2026-04-06 | +12.5% |
| 2026-02-04 | Citigroup | Neutral | maintained | $366.20 | $345 | reached 2026-04-06 | +14.2% |
| 2026-02-04 | Morgan Stanley | Equal-Weight | maintained | $366.20 | $309 | replaced 2026-04-10, new $326 | +14.2% |
| 2026-02-04 | Cantor Fitzgerald | Neutral | maintained | $366.20 | $350 | within 5% of price when set | +14.2% |
| 2026-02-04 | Leerink Partners | Outperform | maintained | $366.20 | $355 | within 5% of price when set | +14.2% |
| 2026-01-26 | UBS | Buy | maintained | $349.69 | $390 | replaced 2026-04-13, new $400 | +5.0% |
| 2026-01-20 | Bernstein | Outperform → Market Perform | downgrade | $331.00 | $335 | within 5% of price when set | +1.1% |
| 2026-01-08 | Truist Securities | Hold | maintained | $330.11 | $319 | within 5% of price when set | +5.2% |
| 2025-12-12 | Morgan Stanley | Equal-Weight | maintained | $317.74 | $304 | within 5% of price when set | -5.5% |
| 2025-12-10 | Wells Fargo | Equal-Weight | maintained | $315.38 | $325 | within 5% of price when set | -2.6% |
| 2025-12-03 | BMO Capital | Outperform | maintained | $345.42 | $372 | reached 2026-02-06 | +16.6% |
| 2025-11-27 | Leerink Partners | Outperform | maintained | $345.46 | $305 | replaced 2026-02-04, new $355 | — |
| 2025-11-14 | Piper Sandler | Overweight | maintained | $336.74 | $381 | reached 2026-02-06 | — |
| 2025-11-12 | Freedom Broker | Hold | maintained | $336.28 | $360 | reached 2026-02-04 | — |
| 2025-11-06 | Cantor Fitzgerald | Neutral | maintained | $315.59 | $315 | within 5% of price when set | — |
| 2025-11-05 | Morgan Stanley | Equal-Weight | maintained | $319.86 | $329 | within 5% of price when set | — |
| 2025-11-05 | Wells Fargo | Overweight | maintained | $319.86 | $300 | replaced 2025-12-10, new $325 | — |
Also in Biotech
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.